Dapagliflozin Patient Satisfaction Survey

Inclusion Criteria: * At least one pharmacy claim for dapagliflozin or dapagliflozin/metformin ER in the most recent month of pharmacy data and no pharmacy claims for an SGLT2 medication during the 6 months prior to sample identification. * Evidence of T2D diagnosis. * Age ≥18 as of the drug index date. * 6 months of continuous enrollment in a commercial health plan with both pharmacy and medical benefits during the identification period through the patient interview sample identification date. * Self-reported T2D diagnosis during the patient interview. Exclusion Criteria: * Patients with evidence of type 1 diabetes mellitus and unknown type * Patients who are pregnant